Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer... von LARA, Primo N, DOUILLARD, Jean-Yves, FANDI, Abderrahim, SCAGLIOTTI, Giorgio, NAKAGAWA, Kazuhiko, VON PAWEL, Joachim, MCKEAGE, Mark J, ALBERT, Istvan, LOSONCZY, György, RECK, Martin, HEO, Dae-Seog, FAN, Xiaolin

Volltext

Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan–Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non–Small-C... von RAMALINGAM, Suresh S, BLACKHALL, Fiona, LETRENT, Stephen P, RUIZ-GARCIA, Ana, TAYLOR, Ian, LIANG, Jane Q, CAMPBELL, Alicyn K, O'CONNELL, Joseph, BOYER, Michael, KRZAKOWSKI, Maciej, BARRIOS, Carlos H, PARK, Keunchil, BOVER, Isabel, DAE SEOG HEO, ROSELL, Rafael, TALBOT, Denis C, FRANK, Richard

Volltext

Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor von Park, Sehhoon, Ha, Seunggyun, Lee, Se-Hoon, Paeng, Jin Chul, Keam, Bhumsuk, Kim, Tae Min, Kim, Dong-Wan, Heo, Dae Seog

Volltext

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis von Keam, Bhumsuk, Im, Seock-Ah, Lee, Kyung-Hun, Han, Sae-Won, Oh, Do-Youn, Kim, Jee Hyun, Lee, Se-Hoon, Han, Wonshik, Kim, Dong-Wan, Kim, Tae-You, Park, In Ae, Noh, Dong-Young, Heo, Dae Seog, Bang, Yung-Jue

Volltext

Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-... von Miller, Vincent A, Prof, Hirsh, Vera, MD, Cadranel, Jacques, Prof, Chen, Yuh-Min, MD, Park, Keunchil, Prof, Kim, Sang-We, Prof, Zhou, Caicun, Prof, Su, Wu-Chou, Prof, Wang, Mengzhao, Prof, Sun, Yan, Prof, Heo, Dae Seog, Prof, Crino, Lucio, Prof, Tan, Eng-Huat, MD, Chao, Tsu-Yi, Prof, Shahidi, Mehdi, MD, Cong, Xiuyu Julie, PhD, Lorence, Robert M, MD, Yang, James Chih-Hsin, Prof

Volltext

Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma von Lenz, Georg, Hawkes, Eliza, Verhoef, Gregor, Haioun, Corinne, Thye Lim, Soon, Seog Heo, Dae, Ardeshna, Kirit, Chong, Geoffrey, Haaber, Jacob, Shi, Wei, Gorbatchevsky, Igor, Lippert, Susanne, Hiemeyer, Florian, Piraino, Paolo, Beckmann, Georg, Peña, Carol, Buvaylo, Viktoriya, Childs, Barrett H., Salles, Gilles

Volltext

The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors von Kim, Hyungjin, Park, Chang Min, Keam, Bhumsuk, Park, Sang Joon, Kim, Miso, Kim, Tae Min, Kim, Dong-Wan, Heo, Dae Seog, Goo, Jin Mo

Volltext

Extranodal NK / T‐cell lymphoma, nasal type: New staging system and treatment strategies von Kim, Tae Min, Heo, Dae Seog

Volltext

Splenic infarction associated with acute infectious mononucleosis due to Epstein–Barr virus infection von Heo, Dae‐Hyuk, Baek, Dae‐Youb, Oh, Sang‐Min, Hwang, Joo‐Hee, Lee, Chang‐Seop, Hwang, Jeong‐Hwan

Volltext

Anthelmintics as Potential Anti-Cancer Drugs? von Heo, Dae Seog

Volltext

Novel JAK3 -Activating Mutations in Extranodal NK/T-cell Lymphoma, Nasal Type von Sim, Sung H, Kim, Soyeon, Kim, Tae M, Jeon, Yoon K, Nam, Soo J, Ahn, Yong-Oon, Keam, Bhumsuk, Park, Hyun H, Kim, Dong-Wan, Kim, Chul W, Heo, Dae S

Volltext

Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment von Oh, So Yeon, Kim, Soyeon, Keam, Bhumsuk, Kim, Tae Min, Kim, Dong-Wan, Heo, Dae Seog

Volltext

Power conversion system integrating OBC and LDC using tapped transformers for weight, volume, and cost reductions in electric vehicles von Heo, Dae-Ho, Kwak, Yun-Gi, Kang, Feel-Soon, Lee, Byoung-Hee

Volltext

Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib von HAN, Sae-Won, KIM, Tae-You, IM, Seock-Ah, YOUNG TAE KIM, JONG SEOK LEE, DAE SEOG HEO, BANG, Yung-Jue, NOE KYEONG KIM, PIL GYU HWANG, JEONG, Soohyun, KIM, Jeongmi, IN SIL CHOI, OH, Do-Youn, JEE HYUN KIM, KIM, Dong-Wan, DOO HYUN CHUNG

Volltext

Reliability and Characteristic Analysis Considering the Circuit Structure and Operation Risk of Forward Converters von Kwak, Yun-Gi, Heo, Dae-Ho, Kang, Feel-Soon

Volltext

GMP-compliant, large-scale expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells in vitro and in vivo von Lim, Okjae, Lee, Yuna, Chung, Hyejin, Her, Jung Hyun, Kang, Sang Mi, Jung, Mi-young, Min, Bokyung, Shin, Hyejin, Kim, Tae Min, Heo, Dae Seog, Hwang, Yu Kyeong, Shin, Eui-Cheol

Volltext

Volatile sulfide compounds and oral microorganisms on the inner surface of masks in individuals with halitosis during COVID-19 pandemic von Lee, Yeon-Hee, Kim, Hyeongrok, Heo, Dae Wook, Ahn, In-Suk, Auh, Q-Schick

Volltext

Severe late dysphagia after multimodal treatment of stage III/IV laryngeal and hypopharyngeal cancer von Huh, Gene, Ahn, Soon-Hyun, Suk, Jun-Girl, Lee, Min-Hyung, Kim, Won Shik, Kwon, Seong Keun, Ock, Chan-Young, Keam, Bhumsuk, Heo, Dae Seog, Kim, Jin Ho, Wu, Hong-Gyun

Volltext

Long-term oncological and functional outcomes of induction chemotherapy followed by (chemo)radiotherapy vs definitive chemoradiotherapy vs surgery-based therapy in locally advanced... von Chung, Eun-Jae, Jeong, Woo-Jin, Jung, Young Ho, Kwon, Seong Keun, Kwon, Tack-Kyun, Ahn, Soon-Hyun, Sung, Myung-Whun, Keam, Bhumsuk, Heo, Dae-Seog, Kim, Jin Ho, Wu, Hong-Gyun, Lee, Keun-Wook, Eom, Keun-Yong, Rho, Young-Soo

Volltext

Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer von Keam, Bhumsuk, Kim, Dong-Wan, Park, Jin Hyun, Lee, Jeong-Ok, Kim, Tae Min, Lee, Se-Hoon, Chung, Doo Hyun, Heo, Dae Seog

Volltext